Litcius/Paper detail

Response to Letter to the Editor: Efficacy and Safety of Sintilimab Plus Pemetrexed and Platinum as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC: A Randomized, Double-Blind, Phase 3 Study (ORIENT-11)

Yunpeng Yang, Hui Zhou, Li Zhang

2020Journal of Thoracic Oncology24 citationsDOIOpen Access PDF

Topics & Concepts

MedicinePembrolizumabPemetrexedClinical endpointLung cancerInternal medicineOncologyRegimenPopulationClinical trialFamily medicineCancerChemotherapyImmunotherapyEnvironmental healthCisplatinCancer Immunotherapy and BiomarkersLung Cancer Treatments and MutationsPancreatic and Hepatic Oncology Research
Response to Letter to the Editor: Efficacy and Safety of Sintilimab Plus Pemetrexed and Platinum as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC: A Randomized, Double-Blind, Phase 3 Study (ORIENT-11) | Litcius